Sierentz, France

Pascal Rigollier

USPTO Granted Patents = 8 


Average Co-Inventor Count = 7.2

ph-index = 7

Forward Citations = 126(Granted Patents)


Location History:

  • Mulhouse, FR (1997)
  • Sierentz, FR (1996 - 1998)
  • Hagenthal-le-Bas, FR (2023)

Company Filing History:


Years Active: 1996-2023

where 'Filed Patents' based on already Granted Patents

8 patents (USPTO):

Title: **Pascal Rigollier: Innovator in Anti-Cancer and Antihypertensive Agents**

Introduction

Pascal Rigollier, a talented inventor based in Sierentz, France, has made significant contributions to the field of pharmaceutical sciences. With a total of 8 patents to his name, Rigollier's work focuses on developing innovative compounds that serve as therapeutic agents, particularly in the treatment of cancer and hypertension.

Latest Patents

Among his latest innovations, Rigollier has developed two notable patents. The first is titled “Pyrazolyl Derivatives Useful as Anti-Cancer Agents.” This invention encompasses a compound defined by a specific formula, offering various stereoisomers and pharmacologically acceptable salts. The patent details the manufacturing process of the compound and its therapeutic applications, including a combination of pharmacologically active agents. The second patent involves “Azido Containing Tetrahydrofuran Compounds.” This invention describes .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides, which exhibit renin-inhibiting properties, positioning them as effective antihypertensive medicinal active ingredients.

Career Highlights

Pascal Rigollier's career spans several esteemed organizations, notably Ciba-Geigy Corporation and Novartis Corporation. His time at these companies has been marked by a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout his career, Rigollier has had the opportunity to collaborate with talented colleagues, including Stefan Stutz and Peter Herold. These collaborations have likely contributed to the successful development and patenting of his innovative pharmaceutical compounds.

Conclusion

In summary, Pascal Rigollier stands out as a remarkable inventor whose patents in anti-cancer and antihypertensive agents reflect his dedication to improving healthcare through innovative solutions. His contributions mark important advancements in pharmacology, showcasing the impact of collaboration and research in developing new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…